Comment on: Dogs and monkeys in preclinical drug development: the challenge of reducing and replacing

By Brown Jeffrey  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 12, 2013-12 ,pp. : 1677-1678

Informa Healthcare

Access to resources Recommend Favorite

Metabonomics in preclinical drug development

By Robertson Donald G   Reily Michael D   Baker J David  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 3, 2005-10 ,pp. : 363-376

Informa Healthcare

Access to resources Recommend Favorite

A Review of: "Preclinical Drug Development"

By Keep Marcus F.  

Drug Development and Industrial Pharmacy, Vol. 33, Iss. 4, 2007-04 ,pp. : 493-493

Informa Healthcare

Access to resources Recommend Favorite

Preclinical drug development for childhood cancer

By Moreno Lucas   Chesler Louis   Hargrave Darren   Eccles Suzanne A   Pearson Andrew DJ  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 1, 2011-01 ,pp. : 49-64

Informa Healthcare

Access to resources Recommend Favorite

Recent advances in preclinical drug development in multiple sclerosis

By Hoban C.J.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 7, 1998-07 ,pp. : 831-854

Informa Healthcare

Access to resources Recommend Favorite